Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Elevation of MMP-9 and IDO induced by pancreatic cancer cells mediates natural killer cell dysfunction
Yunpeng Peng, Jingjing Zhang, Wenbiao Liang, et al.
BMC Cancer (2014) Vol. 14, Iss. 1
Open Access | Times Cited: 79

Showing 1-25 of 79 citing articles:

The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses
Alireza Labani‐Motlagh, Mehrnoush Ashja-Mahdavi, Angelica Loskog
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 599
Tumor microenvironment participates in metastasis of pancreatic cancer
Bo Ren, Ming Cui, Gang Yang, et al.
Molecular Cancer (2018) Vol. 17, Iss. 1
Open Access | Times Cited: 500
Natural killer group 2D receptor and its ligands in cancer immune escape
Shixin Duan, Weihua Guo, Zuxing Xu, et al.
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 204
The Immune Microenvironment in Pancreatic Cancer
Magdalena Huber, Corinna U. Brehm, Thomas M. Gress, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 19, pp. 7307-7307
Open Access | Times Cited: 193
Hypoxia as a barrier to immunotherapy in pancreatic adenocarcinoma
Sara K. Daniel, Kevin M. Sullivan, Kevin P. Labadie, et al.
Clinical and Translational Medicine (2019) Vol. 8, Iss. 1
Open Access | Times Cited: 175
Current advances and outlooks in immunotherapy for pancreatic ductal adenocarcinoma
Jiaqiao Fan, Mengfei Wang, Hailong Chen, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 170
Regulation and modulation of antitumor immunity in pancreatic cancer
Joshua Leinwand, George Miller
Nature Immunology (2020) Vol. 21, Iss. 10, pp. 1152-1159
Closed Access | Times Cited: 167
Neutrophil extracellular traps in homeostasis and disease
Han Wang, Susan J. Kim, Lei Yu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 25
Angiogenin and the MMP9‐TIMP2 axis are up‐regulated in proangiogenic, decidual NK‐like cells from patients with colorectal cancer
Antonino Bruno, Barbara Bassani, Davide Giuseppe D’Urso, et al.
The FASEB Journal (2018) Vol. 32, Iss. 10, pp. 5365-5377
Open Access | Times Cited: 104
3D approaches to model the tumor microenvironment of pancreatic cancer
Elena Tomás Bort, Markus Kieler, Shreya Sharma, et al.
Theranostics (2020) Vol. 10, Iss. 11, pp. 5074-5089
Open Access | Times Cited: 96
Immunotherapy in pancreatic ductal adenocarcinoma: an emerging entity?
İbrahim Halil Şahin, Gokce Askan, Zhengming Hu, et al.
Annals of Oncology (2017) Vol. 28, Iss. 12, pp. 2950-2961
Open Access | Times Cited: 94
The footprint of kynurenine pathway in every cancer: a new target for chemotherapy
Moein Ala
European Journal of Pharmacology (2021) Vol. 896, pp. 173921-173921
Closed Access | Times Cited: 87
Defective Localization With Impaired Tumor Cytotoxicity Contributes to the Immune Escape of NK Cells in Pancreatic Cancer Patients
Seon Ah Lim, Jungwon Kim, Seunghyun Jeon, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 81
The Impact of Matrix Metalloproteinase-9 on the Sequential Steps of the Metastatic Process
Giovanni Barillari
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 12, pp. 4526-4526
Open Access | Times Cited: 79
Small extracellular vesicles: from mediating cancer cell metastasis to therapeutic value in pancreatic cancer
Wenjie Zhang, Juan Xing, Tian Liu, et al.
Cell Communication and Signaling (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 46
Current Limitations and Novel Perspectives in Pancreatic Cancer Treatment
Steve Robatel, Mirjam Schenk
Cancers (2022) Vol. 14, Iss. 4, pp. 985-985
Open Access | Times Cited: 43
Molecular and metabolic regulation of immunosuppression in metastatic pancreatic ductal adenocarcinoma
Shailendra K. Gautam, Surinder K. Batra, Maneesh Jain
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 39
Interactions of IDO and the Kynurenine Pathway with Cell Transduction Systems and Metabolism at the Inflammation–Cancer Interface
Trevor W. Stone, Richard Williams
Cancers (2023) Vol. 15, Iss. 11, pp. 2895-2895
Open Access | Times Cited: 27
Targeting Triple NK Cell Suppression Mechanisms: A Comprehensive Review of Biomarkers in Pancreatic Cancer Therapy
Sara Fanijavadi, Mads Thomassen, Lars Henrik Jensen
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 515-515
Open Access | Times Cited: 1
Strategies for Combining Immunotherapy with Radiation for Anticancer Therapy
Steven N. Seyedin, Jonathan E. Schoenhals, Dean A. Lee, et al.
Immunotherapy (2015) Vol. 7, Iss. 9, pp. 967-980
Open Access | Times Cited: 89
Phosphoinositide 3-Kinase Signaling Pathway in Pancreatic Ductal Adenocarcinoma Progression, Pathogenesis, and Therapeutics
Divya Murthy, Kuldeep S. Attri, Pankaj K. Singh
Frontiers in Physiology (2018) Vol. 9
Open Access | Times Cited: 80
Regulation of Natural Killer Cell Function by STAT3
Nicholas A. Cacalano
Frontiers in Immunology (2016) Vol. 7
Open Access | Times Cited: 74
NK cells in pancreatic cancer demonstrate impaired cytotoxicity and a regulatory IL-10 phenotype
Francesca Marcon, Jianmin Zuo, Hayden Pearce, et al.
OncoImmunology (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 67
Tumor Microenvironment-Associated Extracellular Matrix Components Regulate NK Cell Function
Gustavo Rodrigues Rossi, Edvaldo da Silva Trindade, Fernando Souza‐Fonseca‐Guimaraes
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 56
IDO1/TDO dual inhibitor RY103 targets Kyn-AhR pathway and exhibits preclinical efficacy on pancreatic cancer
Heng Liang, Tianqi Li, Xin Fang, et al.
Cancer Letters (2021) Vol. 522, pp. 32-43
Closed Access | Times Cited: 41
Page 1 - Next Page

Scroll to top